LEAD programme Liraglutide Effect and Action in Diabetes
004940541 044 - Medical and Vet Services Registration expired

Classification Information

  • 16 Publications related to medical studies and research regarding pharmaceutical preparations for the treatment of diabetes related diseases and disorders.
  • 42 Medical and scientific research, namely, conducting clinical trials and studies for pharmaceutical preparations related to the treatment of diabetes related diseases and disorders and providing scientific information on the efficacy of pharmaceutical preparations for the treatment of diabetes related diseases and disorders.
  • 44 Providing medical information on the efficacy of pharmaceutical preparations for the treatment of diabetes related diseases and disorders.

Owners

ID
Organisation Novo Nordisk A/S
Legal status Legal entity
Country DK - Denmark
State/county n/a
Town Bagsværd
Post code 2880
Address Novo Allé
Correspondence address Novo Nordisk A/SCorporate TrademarksNovo AlléDK-2880 BagsværdDINAMARCA

Correspondence

Filing numberSubjectDate
009774715L609A - Notification of expiry27/10/2016
009774715L601A — Notification of the need to renew a EUTM registration AUTOMATIC10/08/2015
004940541Certificate15/09/2008
004940541L304 – Cover letter for registration certificate15/09/2008
003028365T725M - Registration of recordal C.2.2 / B.9.225/02/2008
003028365Sender checklist12/02/2008
003028365Miscellaneous12/02/2008
003028365Letter to the EUIPO12/02/2008
003028365Sender checklist12/02/2008
003028365Miscellaneous12/02/2008
Filter by